Standardized mapping of nursing assessments across 59 U.S. military treatment facilities.

Objective: Create an interoperable set of nursing flowsheet assessment measures within military treatment facility electronic health records using the 3M Healthcare Data Dictionary (HDD).

Design: The project comprised three phases: 1) discovery included an in-depth analysis of the Essentris data to be mapped in the HDD; 2) mapping encompassed the creation of standard operating procedures, mapping heuristics, and the development of mapping tools; and 3) quality assurance incorporated validation of mappings using inter-rater agreement.

Results: Of 569,073 flowsheet concepts, 92% were mapped to the HDD.

Achieving "meaningful use" of electronic health records through the integration of the Nursing Management Minimum Data Set.

Objective: To update the definitions and measures for the Nursing Management Minimum Data Set (NMMDS).

Background: Meaningful use of electronic health records includes reuse of the data for quality improvement. Nursing management data are essential to explain variances in outcomes.

Integrating the nursing management minimum data set into the logical observation identifier names and codes system.

This poster describes the process used to integrate the Nursing Management Minimum Data Set (NMMDS), an instrument to measure the nursing context of care, into the Logical Observation Identifier Names and Codes (LOINC) system to facilitate contextualization of quality measures. Integration of the first three of 18 elements resulted in 48 new codes including five panels. The LOINC Clinical Committee has approved the presented mapping for their next release.

Endothelial cell recovery between comparator polymer-based drug-eluting stents.

Objectives: The purpose of this study was to assess trends in endothelial coverage and recovery among leading polymer-based drug-eluting stents (DES).

Background: Autopsy studies of human U.S.

Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel.

Background: Paclitaxel (PXL)-eluting stents in animals cause incomplete healing and, in some instances, a lack of sustained suppression of neointimal growth. The present study tested the efficacy of a novel systemic delivery nanoparticle PXL for reducing in-stent restenosis.

Methods And Results: A saline-reconstituted formulation of PXL stabilized by albumin nanoparticles (nPXL) was tested in 38 New Zealand White rabbits receiving bilateral iliac artery stents.